Wealth Enhancement Advisory Services’s Corcept Therapeutics CORT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.06M	Sell	73,375 -2,903	-4%	-$312K	0.01%	821
2026 Q2	$6.65M	Buy	+76,278	New	+$4.61M	0.01%	854
2026 Q1	–	Sell	-21,552	Closed	-$771K	–	3636
2025 Q4	$771K	Buy	21,552 +803	+4%	+$63.1K	﹤0.01%	2134
2025 Q3	$1.87M	Buy	20,749 +7,102	+52%	+$514K	﹤0.01%	1479
2025 Q2	$986K	Buy	13,647 +5,693	+72%	+$413K	﹤0.01%	1765
2025 Q1	$909K	Buy	7,954 +230	+3%	+$14K	﹤0.01%	1648
2024 Q4	$389K	Buy	7,724 +2,578	+50%	+$135K	﹤0.01%	2175
2024 Q3	$238K	Buy	+5,146	New	+$183K	﹤0.01%	2336

Other funds holding CORT

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Wealth Enhancement Advisory Services's CORT Position: Q3 2026 in Review

Wealth Enhancement Advisory Services reduced its Corcept Therapeutics (CORT) stake by 3.8% in Q3 2026, selling an estimated $312K and leaving 73,375 shares worth $8.06M. The position accounts for 0.01% of the portfolio, ranked #821.

Wealth Enhancement Advisory Services first reported a position in CORT in Q3 2024 and has held it in 8 quarters since. 118 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

Wealth Enhancement Advisory Services held 73,375 shares of Corcept Therapeutics worth $8.06M as of Q3 2026.
Wealth Enhancement Advisory Services sold 2,903 Corcept Therapeutics shares in Q3 2026, an estimated $312K.
Corcept Therapeutics made up 0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #821 holding.
Wealth Enhancement Advisory Services first reported a position in Corcept Therapeutics in Q3 2024 and has held it in 8 quarters since.
118 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.